Literature DB >> 20036306

Protective effect of post-ischemic treatment with trans-resveratrol on cytokine production and neutrophil recruitment by rat liver.

Sahar Hassan-Khabbar1, Michel Vamy, Charles-Henry Cottart, Dominique Wendum, Françoise Vibert, Jean-François Savouret, Patrice Thérond, Jean-Pierre Clot, Anne-Judith Waligora, Valérie Nivet-Antoine.   

Abstract

Oxidative and inflammatory processes are elicited during hepatic post-ischemic reperfusion and generate liver damage. This study investigated the early anti-inflammatory effect of trans-resveratrol (T-res) and its consequences on the late self-aggravating inflammatory process in liver ischemia-reperfusion (I/R). Partial hepatic ischemia was initiated in rats for 1 h and T-res (0.02 and 0.2 mg/kg) was administered intravenously 5 min before starting reperfusion for 3 h. Plasma levels of aminotransferases and cytokines (tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta, IL-6) and hepatic neutrophil recruitment were assessed. Hepatic expression of stress protein (heat-shock protein (HSP-70), heme oxygenase-1(HO-1)) and cytokine (TNF-alpha, IL-1beta, keratinocyte chemoattractant (KC)) mRNA was investigated. I/R caused an increase in aminotransferase levels and increased polymorphonuclear cell infiltration. Post-ischemic treatment with T-res (0.02 and 0.2 mg/kg) resulted in a significant decrease in aminotransferase, IL-1beta and IL-6 plasma levels by about 40%, 60% and 40%, respectively, compared to the vehicle I/R group. Post-ischemic treatment with T-res (0.02 mg/kg) also significantly decreased hepatic neutrophil recruitment. TNF-alpha, IL-1beta, KC and HO-1 hepatic mRNA expression was reduced by T-res without any change in HSP-70 mRNA. This T-res mediated decrease in early release of cytokines and neutrophil recruitment led to a reduction in the late inflammatory process. T-resveratrol might be useful in the prevention of inflammation secondary to hepatic surgery or liver transplantation. Copyright (c) 2009 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20036306     DOI: 10.1016/j.biochi.2009.12.009

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  10 in total

1.  Resveratrol Decreases TXNIP mRNA and Protein Nuclear Expressions With an Arterial Function Improvement in Old Mice.

Authors:  Tatiana Bedarida; Stephanie Baron; Françoise Vibert; Audrey Ayer; Daniel Henrion; Elizabeth Thioulouse; Carmen Marchiol; Jean-Louis Beaudeux; Charles-Henry Cottart; Valerie Nivet-Antoine
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-06-03       Impact factor: 6.053

2.  Resveratrol prevents protein nitration and release of endonucleases from mitochondria during acetaminophen hepatotoxicity.

Authors:  Kuo Du; Mitchell R McGill; Yuchao Xie; Mary Lynn Bajt; Hartmut Jaeschke
Journal:  Food Chem Toxicol       Date:  2015-04-09       Impact factor: 6.023

3.  Resveratrol effectively attenuates α-naphthyl-isothiocyanate-induced acute cholestasis and liver injury through choleretic and anti-inflammatory mechanisms.

Authors:  Tao Wang; Zhi-xing Zhou; Li-xin Sun; Xia Li; Zhi-meng Xu; Mi Chen; Guo-lin Zhao; Zhen-zhou Jiang; Lu-yong Zhang
Journal:  Acta Pharmacol Sin       Date:  2014-11-24       Impact factor: 6.150

Review 4.  Critical review of resveratrol in xenobiotic-induced hepatotoxicity.

Authors:  Mitchell R McGill; Kuo Du; James L Weemhoff; Hartmut Jaeschke
Journal:  Food Chem Toxicol       Date:  2015-11-10       Impact factor: 6.023

5.  Mangafodipir protects against hepatic ischemia-reperfusion injury in mice.

Authors:  Romain Coriat; Mahaut Leconte; Niloufar Kavian; Sassia Bedda; Carole Nicco; Christiane Chereau; Claire Goulvestre; Bernard Weill; Alexis Laurent; Frédéric Batteux
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

Review 6.  Organ-Protective Effects of Red Wine Extract, Resveratrol, in Oxidative Stress-Mediated Reperfusion Injury.

Authors:  Fu-Chao Liu; Hsin-I Tsai; Huang-Ping Yu
Journal:  Oxid Med Cell Longev       Date:  2015-06-16       Impact factor: 6.543

7.  The Protective Effects of Trypsin Inhibitor on Hepatic Ischemia-Reperfusion Injury and Liver Graft Survival.

Authors:  Lianyue Guan; Hongyu Liu; Peiyao Fu; Zhuonan Li; Peidong Li; Lijuan Xie; Mingang Xin; Zhanpeng Wang; Wei Li
Journal:  Oxid Med Cell Longev       Date:  2015-12-13       Impact factor: 6.543

8.  Resveratrol promotes liver cell survival in mice liver-induced ischemia-reperfusion through unfolded protein response: a possible approach in liver transplantation.

Authors:  Hamidreza Totonchi; Pooneh Mokarram; Saeed Karima; Ramazan Rezaei; Sanaz Dastghaib; Farhad Koohpeyma; Shokoofe Noori; Negar Azarpira
Journal:  BMC Pharmacol Toxicol       Date:  2022-09-29       Impact factor: 2.605

Review 9.  Resveratrol and liver: A systematic review.

Authors:  Forouzan Faghihzadeh; Azita Hekmatdoost; Payman Adibi
Journal:  J Res Med Sci       Date:  2015-08       Impact factor: 1.852

Review 10.  The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials.

Authors:  Carmine Izzo; Monica Annunziata; Giuseppe Melara; Roberta Sciorio; Marcello Dallio; Mario Masarone; Alessandro Federico; Marcello Persico
Journal:  Nutrients       Date:  2021-03-13       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.